Using specific frequencies of flashing lights and sounds to stimulate the brain’s electrical activity, Cognito Therapeutics believes it can help treat Alzheimer’s disease by energizing neurons and ...
With a pivotal trial of its neuromodulation treatment for Alzheimer’s disease underway—and backed by a fresh influx of more than $70 million in VC funding—Cognito Therapeutics is now in the process of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a Phase 3-ready disease-modifying digital therapeutics company developing a new category of therapeutic treatments for neurodegenerative ...
Alzheimer's disease is a complicated and debilitating disease that has no cure. One startup is testing whether a "disco" of light and sound can slow the disease in patients. Cognito Therapeutics ...
Dr. Paul Solomon has seen more than his fair share of intriguing ideas for treating Alzheimer’s disease, some of them better than others. Over the past few decades, the neuroscientist and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback